HomeInsightsPE

Sun Pharma Advanced Research Company Ltd PE Ratio

Sun Pharma Advanced Research Company Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

13.4 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Sun Pharma Advanced Research Company Ltd

NSE: SPARC

PE

-

Last updated on: Dec 11, 2024

Key Highlights

  • The P/E Ratio of Sun Pharma Advanced Research Company Ltd is 0 as of 11 Dec 9.00 AM .
  • The P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from 0 on March 2023 to 0 on March 2024 . This represents a CAGR of 0.0% over 2 years.
  • The Latest Trading Price of Sun Pharma Advanced Research Company Ltd is ₹ 217.25 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Sun Pharma Advanced Research Company Ltd

No data available

Company Fundamentals for Sun Pharma Advanced Research Company Ltd

No data available

Image

Sun Pharma Advanced Research Company Ltd

NSE: SPARC

Share Price

₹ 217.25

-1.15 (-0.53%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Sun Pharma Advanced Research Company Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharma Advanced Research Company Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024217.25
10 Dec 2024218.4
09 Dec 2024217.7
06 Dec 2024216.75
05 Dec 2024216.65
04 Dec 2024219.1
03 Dec 2024216.7
02 Dec 2024217.4
29 Nov 2024216.6
28 Nov 2024204.3

SWOT Analysis Of Sun Pharma Advanced Research Company Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Sun Pharma Advanced Research Company Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sun Pharma Advanced Research Company Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Sun Pharma Advanced Research Company Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical Revenue of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical Dividend Payout of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in %

About Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
  • The Company works on innovation and new product development for global markets.
  • They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Ltd was incorporated on March 1, 2006 as an innovative and development company.
  • They commenced operations on March 22, 2006.
  • As per Scheme of Arrangement, all assets and liabilities of the Innovative Research & Development business including Novel Drug Delivery System (NDDS) division of Sun Pharmaceuticals Industries' Research & Development undertaking stands transferred and vested in the Company with effect from Appointed date on February 28, 2007.

Sun Pharma Advanced Research Company Ltd News Hub

News

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter

Net Loss of Sun Pharma Advanced Research Company reported to Rs 95.90 crore in the quarter...

Read more

2024-08-05 00:00:00

News

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 107.33 crore in the September 2024 quarter

Net Loss of Sun Pharma Advanced Research Company reported to Rs 107.33 crore in the quarte...

Read more

2024-11-04 00:00:00

News

Sun Pharma Advanced Research Company to convene board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

2024-10-25 00:00:00

News

SPARC drops as Q2 net loss widens to Rs 107 crore

Net sales declined 39.29% year on year (YoY) to 12.86 crore in the quarter ended 30 Septem...

Read more

2024-11-04 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sun Pharma Advanced Research Company Ltd

What is the current PE Ratio of Sun Pharma Advanced Research Company Ltd?

The Current PE Ratio of Sun Pharma Advanced Research Company Ltd is 0.0 as on 11 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Dec 2024.

What was the PE Ratio of Sun Pharma Advanced Research Company Ltd last year?

The PE Ratio of Sun Pharma Advanced Research Company Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Sun Pharma Advanced Research Company Ltd indicate about its stock?

The PE Ratio of Sun Pharma Advanced Research Company Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Sun Pharma Advanced Research Company Ltd.

What is the PE Ratio Growth of Sun Pharma Advanced Research Company Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sun Pharma Advanced Research Company Ltd grew by -% whereas, the EPS ratio grew by 11.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions